Company > News > News - Full text

MPA Pharma acquires majority stake

20.04.2012 14:52

MPA Pharma Handshake

In April 2012 Germany’s MPA Pharma acquired a majority stake in Paranova A/S. For 30 years MPA Pharma and its sales subsidiary EMRAmed have been leading reimporters and parallel importers of EU medicinal products in Germany. “The affiliation allows Paranova to offer Scandinavia’s pharmacies a far broader product range, better delivery capabilities and additional services,” says Erik B. Pfeiffer, Chairman of the Board of Directors of the Paranova Group.

Go back